Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Retained Earnings (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Retained Earnings for 16 consecutive years, with -$254.5 million as the latest value for Q3 2025.

  • Quarterly Retained Earnings rose 0.68% to -$254.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$254.5 million through Sep 2025, up 0.68% year-over-year, with the annual reading at -$316000.0 for FY2024, 1189.66% down from the prior year.
  • Retained Earnings for Q3 2025 was -$254.5 million at Xtant Medical Holdings, down from $152000.0 in the prior quarter.
  • The five-year high for Retained Earnings was $152000.0 in Q2 2025, with the low at -$256.3 million in Q3 2024.
  • Average Retained Earnings over 5 years is -$165.5 million, with a median of -$235.2 million recorded in 2021.
  • The sharpest move saw Retained Earnings plummeted 175444.52% in 2024, then surged 186.86% in 2025.
  • Over 5 years, Retained Earnings stood at -$235.2 million in 2021, then dropped by 3.61% to -$243.7 million in 2022, then skyrocketed by 100.01% to $29000.0 in 2023, then plummeted by 1189.66% to -$316000.0 in 2024, then tumbled by 80451.58% to -$254.5 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$254.5 million, $152000.0, and -$209000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.